The Prognostic Value of SUMO1/Sentrin Specific Peptidase 1 (SENP1) in Prostate Cancer Is Limited to ERG-fusion Positive Tumors Lacking PTEN Deletion

BMC Cancer - United Kingdom
doi 10.1186/s12885-015-1555-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Highly Specific Targeting of the TMPRSS2/ERG Fusion Gene in Prostate Cancer Using Liposomal Nanotechnology

2011English

TMPRSS2-ERG Gene Fusion in Transition Zone Prostate Cancer

Modern Pathology
Forensic MedicinePathology
2010English

A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer

Journal of the National Cancer Institute
Cancer ResearchOncology
2015English

Absence of TMPRSS2:ERG Fusions and PTEN Losses in Prostate Cancer Is Associated With a Favorable Outcome

Modern Pathology
Forensic MedicinePathology
2008English

Loss of the Adhesion Molecule CEACAM1 Is Associated With Early Biochemical Recurrence in TMPRSS2:ERG Fusion Positive Prostate Cancers

International Journal of Cancer
Cancer ResearchOncology
2020English

Correction: Genomic Deletion of Chromosome 12p Is an Independent Prognostic Marker in Prostate Cancer

Oncotarget
Oncology
2017English

TMPRSS2-ERG Fusion Is Frequently Observed in Gleason Pattern 3 Prostate Cancer in a Canadian Cohort

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2009English

Prostate Cancer of Transition Zone Origin Lacks TMPRSS2–ERG Gene Fusion

Modern Pathology
Forensic MedicinePathology
2009English

Loss of PTEN Expression in ERG-negative Prostate Cancer Predicts Secondary Therapies and Leads to Shorter Disease-Specific Survival Time After Radical Prostatectomy

Modern Pathology
Forensic MedicinePathology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy